| |
| |
|
| Insider
Information: |
Frates James M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
318,827 |
|
|
Indirect Shares
|
184,010 |
|
|
| Direct
Value |
$2,148,775 |
|
|
|
Indirect Value
|
$3,642,655 |
|
|
| Total
Shares |
502,837 |
|
|
| Total
Value |
$5,791,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alkermes Plc |
ALKS |
SVP, Alks Inc; CFO ALKS |
2020-05-14 |
91,828 |
2020-05-14 |
155,669 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2021-06-16 |
1,035 |
2021-06-16 |
1,810 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
225,964 |
2024-04-16 |
26,531 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
262 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-03-05 |
4 |
OE |
$12.30 |
$86,100 |
D/D |
7,000 |
100,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-03-19 |
4 |
OE |
$12.30 |
$86,100 |
D/D |
7,000 |
43,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-03-19 |
4 |
AS |
$46.84 |
$327,908 |
D/D |
(7,000) |
36,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-04-09 |
4 |
OE |
$12.30 |
$86,100 |
D/D |
7,000 |
43,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-04-09 |
4 |
AS |
$42.91 |
$300,401 |
D/D |
(7,000) |
36,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-07 |
4 |
AS |
$45.60 |
$320,357 |
D/D |
(7,000) |
36,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-07 |
4 |
OE |
$12.30 |
$99,438 |
D/D |
7,000 |
43,644 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,350 |
40,994 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-17 |
4 |
D |
$43.59 |
$89,447 |
D/D |
(2,052) |
38,942 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
42,692 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-20 |
4 |
D |
$43.98 |
$77,801 |
D/D |
(1,769) |
40,923 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-21 |
4 |
AS |
$44.30 |
$310,088 |
D/D |
(7,000) |
40,923 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-21 |
4 |
OE |
$0.00 |
$104,300 |
D/D |
10,750 |
44,673 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-21 |
4 |
D |
$44.48 |
$78,685 |
D/D |
(1,769) |
42,904 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-28 |
4 |
D |
$45.74 |
$53,927 |
D/D |
(1,179) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
45,404 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-06-11 |
4 |
OE |
$14.90 |
$104,300 |
D/D |
7,000 |
51,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-06-11 |
4 |
AS |
$47.72 |
$334,065 |
D/D |
(7,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-07-09 |
4 |
OE |
$14.90 |
$104,300 |
D/D |
7,000 |
51,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-07-09 |
4 |
AS |
$47.22 |
$331,878 |
D/D |
(7,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-07-16 |
4 |
AS |
$46.50 |
$372,006 |
D/D |
(8,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-07-16 |
4 |
OE |
$8.55 |
$68,400 |
D/D |
8,000 |
52,225 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
Director |
– • – |
2014-07-23 |
4 |
B |
$18.00 |
$90,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-08-13 |
4 |
OE |
$8.55 |
$172,700 |
D/D |
15,000 |
59,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-08-13 |
4 |
AS |
$41.37 |
$620,475 |
D/D |
(15,000) |
44,225 |
0 |
- |
|
262 Records found
|
|
Page 5 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
